期刊
CURRENT PHARMACEUTICAL DESIGN
卷 10, 期 9, 页码 1035-1044出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1381612043452767
关键词
GABA(A) receptor; benzodiazepine; alkaloids; flavonoids; intrinsic efficacy; subtype selectivity; structure-activity relationships; pharmacophore models
The enhancement of GABA-mediated synaptic transmission underlies the pharmacotherapy of various neurological diseases. GABA(A) receptors are thus targets for neuroactive drugs, including classical benzodiazepines, mediating their anxiolytic, hypnotic and anticonvulsant effects via the benzodiazepine site (BZS). Based on findings that low intrinsic efficacy and subtype selectivity can greatly improve the specificity of drugs targeting the BZS, recent research has identified possible drug leads with apparently little side effects. In particular, drug leads of natural sources have been identified as promising candidates. This review describes the advances in the design of effective therapeutics targeting the GABA(A) receptor, focusing on the more recent research on naturally occurring drug leads. This includes discussion on the isolation of neuroactive alkaloids and flavonoids from herbal medicines and their rational development based on structure-activity relationships studies. Interest in the development of effective therapeutics from natural sources is clear and awaits to be seen whether their medicinal potential can be fulfilled.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据